MESILATO DE LENVATINIBE 4 MG CAP DURA CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1468201110016 -
GGREM
532424070034006 -
Código de barras
7898272946316
O que a fonte publica
- Detentor do registro
- SUN FARMACÊUTICA DO BRASIL LTDA
- Princípios ativos
- MESILATO DE LENVATINIBE
- Embalagem
- 4 MG CAP DURA CT BL AL AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Genérico
- Classe terapêutica
- L1H9 - OUTROS ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA KINASE
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "MESILATO DE LENVATINIBE 4 MG CAP DURA CT BL AL AL X 30",
"holder": "SUN FARMACÊUTICA DO BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898272946316"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "532424070034006",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "05.035.244/0001-23",
"priceRegime": "Regulado",
"productName": "MESILATO DE LENVATINIBE",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "4 MG CAP DURA CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "2541.98",
"icms-12": "2888.61",
"icms-17": "3062.63",
"icms-18": "3099.98",
"icms-19": "3138.25",
"icms-20": "3177.48",
"icms-21": "3217.70",
"icms-22": "3258.95",
"icms-23": "3301.27",
"icms-17.5": "3081.19",
"icms-19.5": "3157.74",
"icms-20.5": "3197.46",
"icms-22.5": "3279.98",
"icms-12-alc": "2579.12",
"icms-17-alc": "2734.49",
"icms-18-alc": "2767.83",
"icms-19-alc": "2802.00",
"icms-20-alc": "2837.03",
"icms-21-alc": "2872.94",
"icms-22-alc": "2909.77",
"icms-23-alc": "2947.56",
"withoutTaxes": "2269.62",
"icms-17.5-alc": "2751.06",
"icms-19.5-alc": "2819.41",
"icms-20.5-alc": "2854.87",
"icms-22.5-alc": "2928.55"
},
"pisCofinsList": "Negativa",
"substanceText": "MESILATO DE LENVATINIBE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "3409.98",
"icms-12": "3874.97",
"icms-17": "4108.41",
"icms-18": "4158.51",
"icms-19": "4209.85",
"icms-20": "4262.48",
"icms-21": "4316.43",
"icms-22": "4371.77",
"icms-23": "4428.54",
"icms-17.5": "4133.31",
"icms-19.5": "4236.00",
"icms-20.5": "4289.28",
"icms-22.5": "4399.98",
"icms-12-alc": "3565.48",
"icms-17-alc": "3780.27",
"icms-18-alc": "3826.36",
"icms-19-alc": "3873.60",
"icms-20-alc": "3922.03",
"icms-21-alc": "3971.67",
"icms-22-alc": "4022.59",
"icms-23-alc": "4074.83",
"withoutTaxes": "3137.62",
"icms-17.5-alc": "3803.18",
"icms-19.5-alc": "3897.67",
"icms-20.5-alc": "3946.69",
"icms-22.5-alc": "4048.55"
},
"invalidBarcodes": [],
"activeSubstances": [
"MESILATO DE LENVATINIBE"
],
"therapeuticClass": "L1H9 - OUTROS ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA KINASE",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1468201110016",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1H9",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:532424070034006"